# Perfluorocarbon (ABL-101) Oxygenation for Stroke: Trial With GOLD (Glasgow Oxygen Level Dependent Technology) Imaging Theranostic

> **NCT03463551** · PHASE2 · UNKNOWN · sponsor: **NHS Greater Glasgow and Clyde** · enrollment: 18 (estimated)

## Conditions studied

- Acute Ischaemic Stroke

## Interventions

- **DRUG:** ABL-101
- **OTHER:** 0.9% NaCl

## Key facts

- **NCT ID:** NCT03463551
- **Lead sponsor:** NHS Greater Glasgow and Clyde
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-09
- **Primary completion:** 2019-09
- **Final completion:** 2020-03
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2018-08-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03463551

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03463551, "Perfluorocarbon (ABL-101) Oxygenation for Stroke: Trial With GOLD (Glasgow Oxygen Level Dependent Technology) Imaging Theranostic". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03463551. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*